Hospira Dobutamine 12.5 mg/mL Sterile Concentrate 250 mg/20 mL vial

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

dobutamine hydrochloride, Quantity: 14.01 mg/mL (Equivalent: dobutamine, Qty 12.5 mg/mL)

Verfügbar ab:

Hospira Australia Pty Ltd

INN (Internationale Bezeichnung):

dobutamine hydrochloride

Darreichungsform:

Injection, concentrated

Zusammensetzung:

Excipient Ingredients: sodium metabisulfite; water for injections; hydrochloric acid; sodium hydroxide

Verabreichungsweg:

Intravenous Infusion

Einheiten im Paket:

1 x 20 mL

Klasse:

Medicine Listed (Export Only)

Verschreibungstyp:

Not scheduled. Not considered by committee

Anwendungsgebiete:

Dobutamine is indicated for adults who require inotropic support in the treatment of low output cardiac failure associated with organic heart disease, myocardial infarction, open heart surgery, cardiomyophathies, septic shock and cardiogenic shock. Dobutamine can increase or maintain cardiac output during positive end expiratory pressure ventilation.

Produktbesonderheiten:

Visual Identification: A clear colourless or slightly yellow solution free from visible particulate matter; Container Type: Vial; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Berechtigungsstatus:

Listed (Export Only)

Berechtigungsdatum:

2007-03-27